The tariff classification of Telithromycin (CAS-191114-48-4), imported in bulk form, from France
Issued February 7, 2003 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2941.50.0000
Headings: 2941
Product description
According to The Merck Index (thirteenth edition), Telithromycin is a “[S]emisynthetic macrolide antibiotic of the ketolide class, a group of erythromycin derivatives in which the L-cladinose residue has been replaced by a 3-keto group.” A press release, dated January 27, 2003, found on your client’s website, states, in part, that “Aventis … announced today that it received an approvable letter from the U.S. Food and Drug Administration (FDA) for KETEK (telithromycin) tablets for the treatment of acute exacerbations of chronic bronchitis, acute bacterial sinusitis and community-acquired pneumonia.” Pursuant to the Explanatory Notes to heading 2941, HTS, which indicate, inter alia, that heading 2941, HTS, “[i]ncludes chemically modified antibiotics used as such,”
CBP rationale
the applicable subheading for Telithromycin, imported in bulk form, will be 2941.50.0000, Harmonized Tariff Schedule of the United States (HTS), which provides for “Antibiotics: Erythromycin and its derivatives; salts thereof.
Full text
NY J80608 February 7, 2003 CLA-2-29:RR:NC:2:238 J80608 CATEGORY: Classification TARIFF NO.: 2941.50.0000 Kimberly A. Carlson, Esq. Katten Muchin Zavis Rosenman 525 West Monroe Street, Suite 1600 Chicago, IL 60661-3693 RE: The tariff classification of Telithromycin (CAS-191114-48-4), imported in bulk form, from France Dear Ms. Carlson: In your letter dated January 22, 2003, on behalf of your client, Aventis Pharmaceuticals, Inc., you requested a tariff classification ruling. According to The Merck Index (thirteenth edition), Telithromycin is a “[S]emisynthetic macrolide antibiotic of the ketolide class, a group of erythromycin derivatives in which the L-cladinose residue has been replaced by a 3-keto group.” A press release, dated January 27, 2003, found on your client’s website, states, in part, that “Aventis … announced today that it received an approvable letter from the U.S. Food and Drug Administration (FDA) for KETEK (telithromycin) tablets for the treatment of acute exacerbations of chronic bronchitis, acute bacterial sinusitis and community-acquired pneumonia.” Pursuant to the Explanatory Notes to heading 2941, HTS, which indicate, inter alia, that heading 2941, HTS, “[i]ncludes chemically modified antibiotics used as such,” the applicable subheading for Telithromycin, imported in bulk form, will be 2941.50.0000, Harmonized Tariff Schedule of the United States (HTS), which provides for “Antibiotics: Erythromycin and its derivatives; salts thereof.” The rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →